Antigens and alternatives for control of Anaplasma marginale infection in cattle
- PMID: 14557295
- PMCID: PMC207124
- DOI: 10.1128/CMR.16.4.698-712.2003
Antigens and alternatives for control of Anaplasma marginale infection in cattle
Abstract
Anaplasmosis, a tick-borne cattle disease caused by the rickettsia Anaplasma marginale, is endemic in tropical and subtropical areas of the world. The disease causes considerable economic loss to both the dairy and beef industries worldwide. Analyses of 16S rRNA, groESL, and surface proteins have resulted in the recent reclassification of the order Rickettsiales. The genus Anaplasma, of which A. marginale is the type species, now also includes A. bovis, A. platys, and A. phagocytophilum, which were previously known as Ehrlichia bovis, E. platys, and the E. phagocytophila group (which causes human granulocytic ehrlichiosis), respectively. Live and killed vaccines have been used for control of anaplasmosis, and both types of vaccines have advantages and disadvantages. These vaccines have been effective in preventing clinical anaplasmosis in cattle but have not blocked A. marginale infection. Thus, persistently infected cattle serve as a reservoir of infective blood for both mechanical transmission and infection of ticks. Advances in biochemical, immunologic, and molecular technologies during the last decade have been applied to research of A. marginale and related organisms. The recent development of a cell culture system for A. marginale provides a potential source of antigen for the development of improved killed and live vaccines, and the availability of cell culture-derived antigen would eliminate the use of cattle in vaccine production. Increased knowledge of A. marginale antigen repertoires and an improved understanding of bovine cellular and humoral immune responses to A. marginale, combined with the new technologies, should contribute to the development of more effective vaccines for control and prevention of anaplasmosis.
Figures








Similar articles
-
The natural history of Anaplasma marginale.Vet Parasitol. 2010 Feb 10;167(2-4):95-107. doi: 10.1016/j.vetpar.2009.09.012. Epub 2009 Sep 19. Vet Parasitol. 2010. PMID: 19811876 Review.
-
Vaccination of cattle with Anaplasma marginale derived from tick cell culture and bovine erythrocytes followed by challenge-exposure with infected ticks.Vet Microbiol. 2002 Oct 22;89(2-3):239-251. doi: 10.1016/s0378-1135(02)00206-7. Vet Microbiol. 2002. PMID: 12243900
-
Genetically modified live vaccine offers protective immunity against wild-type Anaplasma marginale tick-transmission challenge.Vaccine. 2024 Oct 24;42(24):126069. doi: 10.1016/j.vaccine.2024.06.036. Epub 2024 Jun 15. Vaccine. 2024. PMID: 38880695
-
Cross-protection between geographically distinct Anaplasma marginale isolates appears to be constrained by limited antibody responses.Transbound Emerg Dis. 2013 Nov;60 Suppl 2:97-104. doi: 10.1111/tbed.12125. Transbound Emerg Dis. 2013. PMID: 24589108 Clinical Trial.
-
Anaplasma marginale and Anaplasma phagocytophilum: Rickettsiales pathogens of veterinary and public health significance.Parasitol Res. 2015 Nov;114(11):3941-57. doi: 10.1007/s00436-015-4698-2. Epub 2015 Sep 7. Parasitol Res. 2015. PMID: 26346451 Review.
Cited by
-
Detection of Anaplasma marginale in Hyalomma asiaticum ticks by PCR assay.Parasitol Res. 2013 Jul;112(7):2697-702. doi: 10.1007/s00436-013-3437-9. Epub 2013 May 2. Parasitol Res. 2013. PMID: 23636309
-
The bacterial microbiome of Dermacentor andersoni ticks influences pathogen susceptibility.ISME J. 2016 Aug;10(8):1846-55. doi: 10.1038/ismej.2015.266. Epub 2016 Feb 16. ISME J. 2016. PMID: 26882265 Free PMC article.
-
Molecular diagnosis and biochemical studies of tick-borne diseases (anaplasmosis and babesiosis) in Aberdeen Angus Cattle in New Valley, Egypt.Vet World. 2020 Sep;13(9):1884-1891. doi: 10.14202/vetworld.2020.1884-1891. Epub 2020 Sep 16. Vet World. 2020. PMID: 33132601 Free PMC article.
-
Molecular diagnosis and genetic diversity of tick-borne Anaplasmataceae agents infecting the African buffalo Syncerus caffer from Marromeu Reserve in Mozambique.Parasit Vectors. 2016 Aug 17;9:454. doi: 10.1186/s13071-016-1715-y. Parasit Vectors. 2016. PMID: 27531003 Free PMC article.
-
Novel genetic variants of Anaplasma phagocytophilum, Anaplasma bovis, Anaplasma centrale, and a novel Ehrlichia sp. in wild deer and ticks on two major islands in Japan.Appl Environ Microbiol. 2006 Feb;72(2):1102-9. doi: 10.1128/AEM.72.2.1102-1109.2006. Appl Environ Microbiol. 2006. PMID: 16461655 Free PMC article.
References
-
- Abdala, A. A., E. Pipano, D. H. Aguirre, A. B. Gaido, M. A. Zurbriggen, A. J. Mangold, and A. A. Guglielmone. 1990. Frozen and fresh Anaplasma centrale vaccines in the protection of cattle against Anaplasma marginale infection. Rev. Elev. Med. Vet. Pays Trop. 43:155-158. - PubMed
-
- Aguirre, D. H., A. C. Bermúdez, A. J. Mangold, and A. A. Guglielmone. 1988. Infección natural con Anaplasma marginale en bovines de raza Hereford, Criolla and Nelore en Tucumán, Argentina. Rev. Latinoam. Microbiol. 30:37-42. - PubMed
-
- Aguirre, D. H., A. B. Gaido, A. A. Abdala, L. G. de Ríos, A. J. Mangold, and A. A. Guglielmone. 1988. Evaluación de la protección conferida contra Anaplasma marginale por una vacuna de A. marginale muerto, una vacuna de Anaplasma centrale vivo y una combinación de ambas en bovinos Holando Argentino. Rev. Med. Vet. (Buenos Aires) 69:13-19.
-
- Aguirre, D. H., A. J. Mangold, L. G. de Ríos, and A. A. Guglielmone. 1991. Respuesta clínica y evolución del peso corporal (Bos taurus) vacunadas simultáneamente contra babesiosis y anaplasmosis con inmunógenos vivos. Med. Vet. (Barcelona) 8:95-101.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources